Access cutting-edge type 1 diabetes treatment through this clinical trial at a research site in Columbus. Study-provided care at no cost to qualified participants.
Access type 1 diabetes specialists in Columbus at no cost
This study follows strict safety protocols and ethical guidelines
All study-related type 1 diabetes treatment provided free
This is a multicenter, randomized, double-blind, parallel, placebo-controlled Phase 3, 2-arm study for treatment. The purpose of this study is to measure change in glycemic control and prandial insulin independency over 52 weeks with teplizumab compared with placebo, both administered by intravenous (IV) infusion, in participants with recently diagnosed Stage 3 type 1 diabetes (T1D) aged 1 to 25 years, on standard insulin therapy.
Sponsor: Sanofi
Check if you qualify for this type 1 diabetes clinical trial in Columbus, GA
If you're searching for type 1 diabetes treatment options in Columbus, GA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Columbus research site is actively enrolling participants for this clinical trial. You'll receive care from experienced type 1 diabetes specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.